Related Experiment Videos
Multinucleated tumor cells and malignant melanoma
M Munzarová1, Z Mechl, A Rejthar
1Research Institute of Clinical and Experimental Oncology, Brno, Czechoslovakia.
Neoplasma
|January 1, 1990
Summary
Multinucleated cells (MC) were found in most tumor samples. Their quantity did not significantly differ between primary tumors, metastases, or across different disease stages or progression rates.
Area of Science:
- Oncology
- Cell Biology
Background:
- Multinucleated cells (MC) are observed in various tissues.
- Their role in tumor progression and metastasis is not fully understood.
Purpose of the Study:
- To quantify multinucleated cells (MC) in primary tumors and metastases.
- To investigate if MC quantity correlates with tumor stage, metastasis type, or disease progression.
Main Methods:
- Cell preparations from tumor lesions (primary, lymph node, dermal/subcutaneous metastases) were analyzed immediately after excision.
- Multinucleated cells (MC) were counted in relation to total cells.
Main Results:
- MC were present in nearly all examined specimens (39 primary lesions, 90 lymph node metastases, 33 dermal/subcutaneous metastases).
- MC were rare (less than 1%) in about one-third of samples.
- No significant differences in MC quantity were observed between primary tumors and metastases, or across different disease stages, progression rates, or time points.
Conclusions:
- The quantity of multinucleated cells (MC) is consistently present across various tumor types and metastatic sites.
- MC quantity does not appear to be a significant indicator of disease progression or stage in the examined cancer specimens.